Literature DB >> 3746133

Contraceptive steroids increase hepatic uptake of chylomicron remnants in healthy young women.

F Berr, R H Eckel, F Kern.   

Abstract

In an investigation of alterations in cholesterol metabolism during contraceptive steroid use, we studied plasma clearance of chylomicron remnants. Six healthy women were studied on and off contraceptive steroid therapy. Remnant clearance was measured from the disappearance of retinyl palmitate administered intravenously in plasma endogenously labeled with retinyl palmitate. We also measured cholesterol in HDL and its subfractions and postheparin lipoprotein lipase and hepatic triglyceride lipase activities. Plasma decay of retinyl palmitate was biexponential. The rapid component, reflecting chylomicron remnant removal, accounted for about 90% of the total clearance in all studies. During contraceptive steroid intake, both rapid and slow decay constants and the calculated plasma clearance rates were significantly increased (mean values: rapid decay constant, control 0.048 versus treated 0.101 min-1, P less than 0.05; slow decay constant, 0.004 versus 0.014 min-1, P less than 0.01; plasma clearance 74 versus 115 ml/min, P less than 0.025) indicating enhanced hepatic uptake of chylomicron remnants and probably an increased hepatic uptake of higher density lipoproteins (d greater than 1.006 g/ml). Total postheparin lipolytic activity and lipoprotein lipase activity were depressed in all six women (P less than 0.05) and hepatic triglyceride lipase activity was increased in four of five subjects. Contraceptive steroids also caused a decrease in the HDL2/HDL3 cholesterol ratio (P less than 0.05), implying impaired peripheral lipoprotein triglyceride hydrolysis and/or increased HDL2 clearance by hepatic triglyceride lipase. In conclusion, during intake of contraceptive steroids, the plasma clearance of chylomicron remnants and higher density lipoproteins was increased.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Keywords:  Biology; Cholesterol; Clinical Research; Contraception; Contraceptive Agents; Contraceptive Agents, Estrogen; Contraceptive Agents, Female; Contraceptive Methods; Endocrine System; Ethinyl Estradiol; Family Planning; Hepatic Effects; Hormones; Ingredients And Chemicals; Lipids; Mestranol; Oral Contraceptives; Organic Chemicals; Physiology; Reproductive Control Agents; Research Methodology

Mesh:

Substances:

Year:  1986        PMID: 3746133

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  11 in total

1.  Metabolic and haemostatic effects of estradiol valerate/dienogest, a novel oral contraceptive: a randomized, open-label, single-centre study.

Authors:  Wolfgang Junge; Uwe Mellinger; Susanne Parke; Marco Serrani
Journal:  Clin Drug Investig       Date:  2011       Impact factor: 2.859

2.  Modeling the dose effects of soybean oil in salad dressing on carotenoid and fat-soluble vitamin bioavailability in salad vegetables.

Authors:  Wendy S White; Yang Zhou; Agatha Crane; Philip Dixon; Frits Quadt; Leonard M Flendrig
Journal:  Am J Clin Nutr       Date:  2017-08-16       Impact factor: 7.045

3.  Dietary polyunsaturated fats of the W-6 and W-3 series reduce postprandial lipoprotein levels. Chronic and acute effects of fat saturation on postprandial lipoprotein metabolism.

Authors:  M S Weintraub; R Zechner; A Brown; S Eisenberg; J L Breslow
Journal:  J Clin Invest       Date:  1988-12       Impact factor: 14.808

Review 4.  Occlusive vascular diseases in oral contraceptive users. Epidemiology, pathology and mechanisms.

Authors:  I F Godsland; U Winkler; O Lidegaard; D Crook
Journal:  Drugs       Date:  2000-10       Impact factor: 9.546

5.  Mechanisms of gallstone formation in women. Effects of exogenous estrogen (Premarin) and dietary cholesterol on hepatic lipid metabolism.

Authors:  G T Everson; C McKinley; F Kern
Journal:  J Clin Invest       Date:  1991-01       Impact factor: 14.808

6.  Dietary fat clearance in normal subjects is regulated by genetic variation in apolipoprotein E.

Authors:  M S Weintraub; S Eisenberg; J L Breslow
Journal:  J Clin Invest       Date:  1987-12       Impact factor: 14.808

7.  Different patterns of postprandial lipoprotein metabolism in normal, type IIa, type III, and type IV hyperlipoproteinemic individuals. Effects of treatment with cholestyramine and gemfibrozil.

Authors:  M S Weintraub; S Eisenberg; J L Breslow
Journal:  J Clin Invest       Date:  1987-04       Impact factor: 14.808

8.  Clearance from plasma of triacylglycerol and cholesteryl ester after intravenous injection of chylomicron-like lipid emulsions in rats and man.

Authors:  T G Redgrave; H L Ly; E C Quintao; C F Ramberg; R C Boston
Journal:  Biochem J       Date:  1993-03-15       Impact factor: 3.857

9.  Impact of hormone replacement therapy on postprandial lipoproteins and lipoprotein(a) in normolipidemic postmenopausal women.

Authors:  U Julius; H Fritsch; W Fritsch; E Rehak; K Fücker; W Leonhardt; M Hanefeld
Journal:  Clin Investig       Date:  1994-07

10.  Clearance of chylomicron remnants in normolipidaemic patients with coronary artery disease: case control study over three years.

Authors:  M S Weintraub; I Grosskopf; T Rassin; H Miller; G Charach; H H Rotmensch; M Liron; A Rubinstein; A Iaina
Journal:  BMJ       Date:  1996-04-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.